Cargando…

Safety Communication Tools and Healthcare Professionals’ Awareness of Specific Drug Safety Issues in Europe: A Survey Study

INTRODUCTION: National competent authorities (NCAs) use Direct Healthcare Professional Communications (DHPCs) to communicate new drug safety issues to healthcare professionals (HCPs). More knowledge is needed about the effectiveness of DHPCs and the extent to which they raise awareness of new safety...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Vries, Sieta T., van der Sar, Maartje J. M., Coleman, Anna Marie, Escudero, Yvette, Rodríguez Pascual, Alfonso, Maciá Martínez, Miguel-Ángel, Cupelli, Amelia, Baldelli, Ilaria, Šipić, Ivana, Andrić, Adriana, Michan, Line, Denig, Petra, Mol, Peter G. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2018
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5990574/ https://www.ncbi.nlm.nih.gov/pubmed/29500798 http://dx.doi.org/10.1007/s40264-018-0643-5

Ejemplares similares

Communication on Safety of Medicines in Europe: Current Practices and General Practitioners’ Awareness and Preferences
por: de Vries, Sieta T., et al.
Publicado: (2017)

Drug Safety Issues Covered by Lay Media: A Cohort Study of Direct Healthcare Provider Communications Sent between 2001 and 2015 in The Netherlands
por: de Vries, Esther, et al.
Publicado: (2020)

Motives to Report Adverse Drug Reactions to the National Agency: A Survey Study among Healthcare Professionals and Patients in Croatia, The Netherlands, and the UK
por: de Vries, Sieta T., et al.
Publicado: (2021)

Sex Differences in Adverse Drug Reactions of Metformin: A Longitudinal Survey Study
por: de Vries, Sieta T., et al.
Publicado: (2020)

Adverse drug event patterns experienced by patients with diabetes: A diary study in primary care
por: Denig, Petra, et al.
Publicado: (2019)

Trends in HbA(1c) thresholds for initiation of hypoglycemic agents: Impact of changed recommendations for older and frail patients
por: Ambrož, Martina, et al.
Publicado: (2020)

Older Age, Polypharmacy, and Low Systolic Blood Pressure Are Associated With More Hypotension-Related Adverse Events in Patients With Type 2 Diabetes Treated With Antihypertensives
por: Ambrož, Martina, et al.
Publicado: (2021)

Less Timely Initiation of Glucose-Lowering Medication Among Younger and Male Patients With Diabetes and Similar Initiation of Blood Pressure-Lowering Medication Across Age and Sex: Trends Between 2015 and 2020
por: Ambrož, Martina, et al.
Publicado: (2022)

Factors Influencing the Use of a Mobile App for Reporting Adverse Drug Reactions and Receiving Safety Information: A Qualitative Study
por: de Vries, Sieta T., et al.
Publicado: (2016)

Interest in a Mobile App for Two-Way Risk Communication: A Survey Study Among European Healthcare Professionals and Patients
por: de Vries, Sieta T., et al.
Publicado: (2018)

Handling of New Drug Safety Information in the Dutch Hospital Setting: A Mixed Methods Approach
por: de Vries, Esther, et al.
Publicado: (2022)

Sex differences in adverse drug reactions reported to the National Pharmacovigilance Centre in the Netherlands: An explorative observational study
por: de Vries, Sieta T., et al.
Publicado: (2019)

Factors Influencing Preferences and Responses Towards Drug Safety Communications: A Conjoint Experiment Among Hospital-Based Healthcare Professionals in the Netherlands
por: de Vries, Esther, et al.
Publicado: (2022)

Changes in blood pressure thresholds for initiating antihypertensive medication in patients with diabetes: a repeated cross-sectional study focusing on the impact of age and frailty
por: Ambrož, Martina, et al.
Publicado: (2020)

Self-Reported Effectiveness and Safety of Trokie(®) Lozenges: A Standardized Formulation for the Buccal Delivery of Cannabis Extracts
por: Crowley, Kenton, et al.
Publicado: (2018)

What Factors Make EU Regulators Want to Communicate Drug Safety Issues Related to SGLT2 Inhibitors? An Online Survey Study
por: Roldan Munoz, Sonia, et al.
Publicado: (2023)

Construct and concurrent validity of a patient-reported adverse drug event questionnaire: a cross-sectional study
por: de Vries, Sieta T, et al.
Publicado: (2014)

Use of a Patient-Friendly Terms List in the Adverse Drug Reaction Report Form: A Database Study
por: de Vries, Sieta T., et al.
Publicado: (2019)

Sex disparities in medication prescribing amongst patients with type 2 diabetes mellitus managed in primary care
por: Ambrož, Martina, et al.
Publicado: (2022)

Safety of Medicines in Europe
por: Griffin, J P
Publicado: (1993)

Prediction of the Effects of Empagliflozin on Cardiovascular and Kidney Outcomes Based on Short-Term Changes in Multiple Risk Markers
por: Tye, Sok Cin, et al.
Publicado: (2022)

Nuclear Science and Safety in Europe
por: Čechák, Tomas, et al.
Publicado: (2006)

The Role of Patients’ Age on Their Preferences for Choosing Additional Blood Pressure-Lowering Drugs: A Discrete Choice Experiment in Patients with Diabetes
por: de Vries, Sieta T., et al.
Publicado: (2015)

Beamline for Schools Safety Awareness Day
por: Photo Service, CERN, et al.
Publicado: (2014)

Putting road safety awareness into practice
Publicado: (2003)

Validity of your safety awareness training
por: DG Unit
Publicado: (2010)

Patient literacy and awareness of medicine safety
por: See, Marissa, et al.
Publicado: (2020)

Lightning safety awareness level in Malaysia
por: Nazri, Khairul, et al.
Publicado: (2021)

Sex Differences in Lipid Profile across the Life Span in Patients with Type 2 Diabetes: A Primary Care-Based Study
por: Ambrož, Martina, et al.
Publicado: (2021)

Safety and tolerability of a 6‐week course of oseltamivir prophylaxis for seasonal influenza in children
por: Reisinger, Keith, et al.
Publicado: (2012)

Prediction of the Effects of Liraglutide on Kidney and Cardiovascular Outcomes Based on Short-Term Changes in Multiple Risk Markers
por: Tye, Sok Cin, et al.
Publicado: (2022)

Recommendations on the Use of Mobile Applications for the Collection and Communication of Pharmaceutical Product Safety Information: Lessons from IMI WEB-RADR
por: Pierce, Carrie E., et al.
Publicado: (2019)

Differences in medication beliefs between pregnant women using medication, or not, for chronic diseases: a cross-sectional, multinational, web-based study
por: Roldan Munoz, Sonia, et al.
Publicado: (2020)

Radiation Safety Awareness Among Medical Staff
por: Szarmach, Arkadiusz, et al.
Publicado: (2015)

Seafood safety: A need for greater awareness
por: Choudhury, Samira, et al.
Publicado: (2022)

Safety awareness and use of child safety seats among parents after the legislation in Shanghai
por: Niu, Lei, et al.
Publicado: (2019)

An analysis on the relationship between safety awareness and safety behaviors of healthcare professionals, Ankara/Turkey
por: Uzuntarla, Fatma, et al.
Publicado: (2020)

Statements on the Safety of Permanent Soft Tissue Fillers in Europe
por: van Dam, Daphne, et al.
Publicado: (2009)

Food safety challenges and One Health within Europe
por: Boqvist, Sofia, et al.
Publicado: (2018)

Utilization and safety of onabotulinumtoxinA for the prophylactic treatment of chronic migraine from an observational study in Europe
por: Matharu, Manjit, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_si123sm39ekeduic36hhcfsl54